If you’re a member of the media working on a story about brain trauma or brain health, we can connect you with the experts at Cohen Veterans Bioscience. Please don’t hesitate to contact us.
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Follow Cohen Veterans Bioscience
Parachuting with a Purpose: Local US Marine Corps Veteran BASE Jumps to Raise Awareness of Veteran SuicideRead more
Pittsburgh Veteran Tristan Wimmer is returning to the skies of his hometown to bring attention to this national crisis. On Jan. 30, 2021, Wimmer will team up with other Veterans to complete 22 BASE jumps — 22 is symbolic of the 22 United States Active Duty and Veterans who succumb to suicide each day.
- Read more
Cohen Veterans Bioscience is pleased to announce the appointment of Dr. Dave DeMarco to its Board of Directors.
- Read more
Null Hypothesis is a collaborative initiative dedicated to publishing well-performed replication and negative studies — or studies where the outcomes do not confirm expected results or working hypotheses — via dedicated journal space.
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric DisordersRead more
Cohen Veterans Bioscience announced findings from a study which generates new evidence in support of a critical brain imaging biomarker, that may help guide people who suffer from post-traumatic stress disorder (PTSD) or major depressive disorder (MDD) towards the most effective treatment.
Global Preclinical Data Forum and European College of Neuropsychopharmacology Announce the Winner of the 2020 Best Negative Data PrizeRead more
The Global Preclinical Data Forum (GPDF), a jointly sponsored U.S. and European initiative, funded by Cohen Veterans Bioscience (CVB) and the European College of Neuropsychopharmacology (ECNP), announced today the winner of the 2020 “Best Negative Data Prize.” The prize is awarded to the researcher or research group whose neuroscience study best exemplifies data where the outcomes do not confirm the expected results or working hypothesis.